Recode Therapeutics To Expand Next-Generation Delivery Platform And Diversify Genetic Medicines Pipeline With Oversubscribed Series B Financing Totaling $200M
Round Type
Series B
Menlo ParkBiotechnologyHealthcareHealth CareDescription
ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of messenger RNA (mRNA) and gene correction therapeutics, today announced the close of a Series B extension financing round, co-led by new investors, Leaps by Bayer, the impact investment unit of Bayer AG, AyurMaya, an affiliate of Matrix Capital Management, and with participation from Amgen Ventures. With the additional $120M in new financing, the company has secured a total of $200M in Series B funding. In connection with the financing, Alan Colowick, M.D., M.P.H., managing director of Matrix, and Rakhshita Dhar, senior director of Venture investments Health at Leaps by Bayer, will join ReCode’s Board of Directors.
Quick answer
ReCode Therapeutics raised an undisclosed amount in a Series B round, dated June 29, 2022. ReCode Therapeutics is based in Menlo Park, California, United States.
- How much did ReCode Therapeutics raise?
- ReCode Therapeutics raised an undisclosed amount in a Series B round on June 29, 2022.
- What does ReCode Therapeutics do?
- ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
- Where is ReCode Therapeutics based and how big is it?
- ReCode Therapeutics is based in Menlo Park, California, United States.
- Who are the decision-makers at ReCode Therapeutics?
- Fundz holds 1 contact at ReCode Therapeutics, including the Head of Clinical Operations | Rare Diseases. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at ReCode Therapeutics, and when
A new round usually means ReCode Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ReCode Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ReCode Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansReCode Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.